Patent US4904475A successfully refreshed from Google Patents.
US4904475A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Transdermal delivery of drugs from an aqueous reservoir
Assignee: Alza Corp
•
Filing: 1987-02-24
•
Granted: 1990-02-27
•
Expires: 2007-02-24
Abstract
Abstract A transdermal delivery device for delivering drugs, typically ionized drugs, from an aqueous reservoir is described. The device comprises an aqueous drug reservoir in the form of a gel confined between an impermeable backing member and a porous support structure. In preferred embodiments the support structure is the substrate to which is applied a porous or patterned in-line adhesive. A strippable release liner is preferably provided on the adhesive while in the package. The devices are usable to deliver drugs such as chlorpheniramine maelate, brompheneiramine maleate and scopolamine hydrobromide.
Inventors
- 👤 Robert M. Gale
- 👤 David J. Enscore
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 12:13
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K9/7084
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
86 words
A medical device for the transdermal delivery of a highly ionized, fat-insoluble drug comprising, in combination: a. aqueous drug reservoir means comprising at least 50% water having said drug dissolved therein; b. receptacle means containing said reservoir means, said receptacle means being substantially impermeable to the contents of said reservoir means; c. highly permeable reservoir retaining means disposed over the skin proximal surface of said aqueous reservoir means; and d. means for maintaining said medical device in permeation enhancer and drug transmitting relationship to the skin.
Claim 2
Dependent Claim
86 words
A medical device for the transdermal delivery of a highly ionized, fat-insoluble drug comprising, in combination: a. aqueous drug reservoir means comprising at least 50% water having said drug dissolved therein; b. receptacle means containing said reservoir means, said receptacle means being substantially impermeable to the contents of said reservoir means; c. highly permeable reservoir retaining means disposed over the skin proximal surface of said aqueous reservoir means; and d. means for maintaining said medical device in permeation enhancer and drug transmitting relationship to the skin.
Claim 3
Dependent Claim
19 words
The medical device of claim 1 wherein the pH of said aqueous reservoir is in the range of 4.5-8.5.
Claim 4
Dependent Claim
24 words
The medical device of claim 2 wherein said drug is selected from the group consisting of the chlorpheniramine maleate, brompheniramine maleate and scopolamine hydrobromade.
Claim 5
Dependent Claim
35 words
The medical device of claim 1 wherein said means for maintaining said medical device on the skin comprises a layer of a permeable adhesive disposed on the skin proximal surface of said reservoir retaining means.
Claim 6
Dependent Claim
13 words
The device of claim 4 wherein said permeable adhesive is a porous adhesive.
Claim 7
Dependent Claim
13 words
The device of claim 4 wherein said permeable adhesive is a patterned adhesive.
Claim 8
Dependent Claim
16 words
The medical device of claim 1 wherein said aqueous reservoir means contains undissolved drug dispersed therethrough.
Claim 9
Dependent Claim
21 words
The medical device of claim 1 wherein said drug is dissolved within said aqueous reservoir means at a level below saturation.
Claim 10
Dependent Claim
33 words
The medical device of claim 1 wherein said means for maintaining said medical device on the skin comprises a peripherally disposed layer of adhesive outside the path of drug flow to the skin.
Claim 11
Dependent Claim
82 words
A medical device for the transdermal delivery of a drug from an aqueous reservoir comprising, in combination: a. an impermeable backing member bonded about its periphery to a perforate support structure, defining in the region there between a drug reservoir receiving volume; b. a drug reservoir comprising an aqueous gel having said drug dispersed therethrough in said reservoir receiving volume and the void space of said perforate support structure; c. a drug permeable adhesive on the exterior of said perforate support structure.
Claim 12
Dependent Claim
82 words
A medical device for the transdermal delivery of a drug from an aqueous reservoir comprising, in combination: a. an impermeable backing member bonded about its periphery to a perforate support structure, defining in the region there between a drug reservoir receiving volume; b. a drug reservoir comprising an aqueous gel having said drug dispersed therethrough in said reservoir receiving volume and the void space of said perforate support structure; c. a drug permeable adhesive on the exterior of said perforate support structure.
Claim 13
Dependent Claim
19 words
The device of claim 10 further comprising a stripable release liner on the surface of said drug permeable adhesive.
Claim 14
Dependent Claim
19 words
The device of claim 10 wherein said adhesive is selected from the group consisting of porous and patterned adhesives.
Claim 15
Dependent Claim
12 words
The device of claim 10 wherein said adhesive is an hydrated adhesive.
Claim 16
Dependent Claim
13 words
The device of claim 12 wherein said gel fills the void volume adhesive.
Claim 17
Dependent Claim
15 words
The device of claim 10 wherein said drug is a highly ionized, fat insoluble drug.
Claim 18
Dependent Claim
22 words
The device of claim 15 wherein said drug is selected from the group consisting of chlorpheniramine maleate, brompheniramine maelate and scopolamine hydrobromide.
Claim 19
Dependent Claim
14 words
The device of claim 10 wherein said support structure is an open pore foam.
Claim 20
Dependent Claim
12 words
The device of claim 10 wherein said support structure is a fabric.
Claim 21
Dependent Claim
23 words
The device of claim 10 wherein said support structure is selected from the group consisting of hydrophobic open pore foams and hydrophobic fabrics.
References Cited (Backward Citations)
US2561071A
Cited
US3339546A
Cited
US3797494A
Cited
US3969498A
Cited
GB1510569A
Cited
US4161283A
Cited
US4470962A
Cited
US4460372A
Cited
US4379454A
Cited
EP0107575A1
Cited
US4695465A
Cited
US4624665A
Cited
US4687481A
Cited
US4645502A
Cited
US4743249A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-02-26 | 1993-08-28 | 1994-02-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-02-26 | 1997-08-28 | 1998-02-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-02-26 | 2001-08-28 | 2002-02-27 | $7700.00 | Window Closed / Lapsed |